Opioid overdose
Opioid receptor agonism → CNS/respiratory depression
Overview
Opioid toxicity causing the classic triad of reduced consciousness, respiratory depression and PINPOINT pupils. Naloxone reverses it — but it is short-acting, so re-sedation must be anticipated, especially with long-acting opioids (methadone).
Recognise
- Reduced consciousness, slow shallow breathing, pinpoint (miotic) pupils
- Hypoventilation/hypoxia, hypotension; track marks/patches/history
- Methadone: prolonged effect + QT prolongation
Red flags
- Apnoea/severe hypoventilation; re-sedation after naloxone wears off (esp. methadone/modified-release)
Differentials & how to tell them apart
Investigations
Clinical (the toxidrome). ABG, glucose, ECG (methadone QT); urine toxicology; consider co-ingestants/paracetamol.
Management
Titrated naloxone (repeat/infuse for long-acting opioids) + airway/ventilation support
- 1Support airway/breathing (BVM oxygen); give titrated naloxone to restore adequate respiration (start low in opioid dependence to avoid acute withdrawal).Gate: Naloxone is SHORT-ACTING — with long-acting opioids (e.g. methadone, modified-release) anticipate re-sedation and use a naloxone infusion + prolonged observation
- 2Observe for re-sedation; treat complications; refer to drug services / safeguard; check ECG if methadone (QT).
Key points
Pinpoint pupils + low RR + low GCS = opioids. Naloxone half-life is shorter than most opioids — never discharge early after a single dose.
Monitor & prognosis
Respiratory rate/SpO2, GCS, repeated naloxone need; ECG if methadone.
Excellent with ventilation + naloxone; deaths are from unobserved re-sedation.
Source: TOXBASE; BNF (naloxone)